Nancy Y. Lee, MD, FASTRO, NIH R01 grant-funded investigator, is Vice Chairman of the Department of Radiation Oncology, focusing on Experimental Therapeutics.  She is also the Proton Service Chief and the Chief of the Head and Neck Radiation Oncology Service at Memorial Sloan Kettering Cancer Center. She is also the Associate Director of the Prevention Interception Program at MSKCC.  She is also the Multimodality Section Head of the Early Drug Development Service.  Dr. Lee has appointments in both Radiation Oncology Department as well as Early Drug Development Group and currently is the Section Head of the Multimodality Therapeutic Section within Early Drug Development.

She is an internationally renowned academic physician whose research, publications (>300 peer-reviewed papers), 3 of the best-selling target delineation books, and lectures have helped radiation oncologists across multiple radiation oncologists harness the powers of IMRT and proton therapy.  She has dedicated her career to embracing technology, modernizing clinical practice, and bringing radiation oncology to the forefront of cancer medicine.  She is also active in the Society for Immunotherapy of Cancer, where she is a co-author of a consensus statement on immunotherapy use for head and neck cancer and has established multiple industry relationships to take command of trials combining novel therapeutic agents with radiation.  Dr. Lee has served on multiple ASTRO committees and editorial boards.  At MSKCC, she has been a tireless advocate for patients and dedicated herself to the education of trainees (receiving multiple ARRO teaching awards and mentoring hundreds of radiation oncologists around the world to successful careers of their own in academic and private practices across the country.